Paladin Labs' P2P Acquisition

Paladin Labs raised a round of funding on February 26, 2014. Investors include Endo International.

Paladin Labs, headquartered in Montreal, Canada, is a specialty pharmaceutical company focused on acquiring or in-licensing innovative pharmaceutical products for the Canadian and world markets. With …

Articles about Paladin Labs' P2P Acquisition: